SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mercury Laboratories informs about board meeting

08 May 2025 Evaluate

Pursuant to Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Mercury Laboratories has informed that a meeting of the Board of Directors of the company will be held on Wednesday, May 14, 2025: 1. To consider and approve the Audited Financial Results of the Company for the quarter and year ended on March 31, 2025 together with the draft Directors’ Report. 2. To consider and recommend dividend for the year ended on March 31, 2025, if any, subject to approval of shareholders at the ensuing Annual General Meeting. 3. To consider and approve appointment of Secretarial Auditor for the Financial Year 2025-26, subject to approval of shareholders. 4. To consider and approve appointment of Internal Auditor for the FY 2025-26. 5. To consider and approve appointment of Cost Auditor for the FY 2025-26. 6. To fix the date, time and venue for the 44th Annual General Meeting and approve the draft notice of the 44th Annual General Meeting of the Company. 7. To consider and approve any other items of Agenda, if any. Further, as per the Company’s Code of Conduct for Prevention of Insider Trading, the company has informed that, the ‘Trading Window’ has already been closed with effect from April 01, 2025 and shall continue to remain closed till 48 hours after the declaration of the audited financial results for the quarter and Year ended on March 31, 2025.

The above information is a part of company’s filings submitted to BSE.

Mercury Laboratories Share Price

799.00 0.00 (0.00%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×